Spotted fever group rickettsiae in Ticks, Morocco.
Tick-borne rickettsioses are infections caused by obligate intracellular gram-negative bacteria of the spotted fever group (SFG) in the genus Rickettsia and the order Rickettsiales. These zoonoses are now recognized as emerging vector-borne infections worldwide (1,2). They share characteristic clinical features, including fever, headache, rash, and occasional eschar formation at the site of the tick bite. Although these diseases have been known for a long time, they have been poorly investigated in northern Africa, including Morocco (2).
Two human tick-borne SFG rickettsioses are known to occur in Morocco. Mediterranean spotted fever, caused by Rickettsia conorii conorii, is transmitted by the brown dog tick, Rhipicephalus sanguineus, which is well adapted to urban environments and is endemic to the Mediterranean area (2). In Morocco, clinicians usually consider patients with spotted fever as having Mediterranean spotted fever. However, in 1997, Beati et al. isolated a new rickettsia, R. aeschlimannii, from Hyalomma marginatum marginatum ticks collected in Morocco (3). In 2002, human infection with this rickettsia was reported in a patient returning from Morocco to France (4).
To date, all studies on rickettsioses conducted in Morocco have been based on only clinical and serologic features. However, the number of representatives of the genus Rickettsia and the number of newly described rickettsioses have increased in recent decades because of improved cell culture isolation techniques and extensive use of bacterial detection and identification by molecular biologic techniques (2). Comparison of the sequences of PCR-amplified fragments of genes encoding 16S rRNA, citrate synthase (gltA), or outer membrane protein (ompA) has become a reliable method for identifying rickettsiae in arthropods, including ticks (1). Therefore, our aim was to detect and characterize rickettsiae in hard ticks collected in Morocco by using PeR and sequence analysis of amplified products and to discuss their potential threat for humans and animals.
Materials and Methods
Collection and Identification of Ticks
From April 2002 through March 2006, ticks were collected from domestic animals (livestock and dogs) and by flagging vegetation at sites in the Taza region in northeastern Morocco. These sites were located between the towns of Babboudir and Babezhare, (34[degrees]12'48.81"N, 4[degrees]0'55.63"W) in the Atlas Mountains, situated 40 km from the city of Taza and 90 km from the city of Fez. All ticks collected were adults and morphologically identified to the species or genus level by using standard taxonomic keys. Ticks were kept in ethanol at room temperature until DNA was extracted in the Laboratoire des Maladies Vectorielles, Institut Pasteur du Maroc, Casablanca, Morocco. DNA samples were thereafter sent to the Unite des Rickettsies in Marseille, France.
PCR Detection and Identification of Rickettsia spp.
Ticks were rinsed with distilled water for 10 min, dried on sterile filter paper in a laminar flow hood, and crushed individually in sterile Eppendorf (Hamburg, Germany) tubes. DNA was extracted by using the QIAamp Tissue Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. Rickettsial DNA was detected by PCR by using primers Rp CS.409p and Rp CS. 1258n (Eurogentec, Seraing, Belgium), which amplify a 750-bp fragment of the gltA gene of Rickettsia spp. as described (5). All ticks positive for gltA were tested for the ompA gene of Rickettsia spp. by using primers Rr. 190.70 and Rr. 190.701, which amplify a 629-632-bp fragment (5). A negative control (distilled water instead of tick DNA template) and a positive control (DNA from R. montanensis) were included in each test. All PCRs were conducted in Marseille by using the GeneAmp PCR System 2400 and 9700 thermal cyclers (PerkinElmer, Waltham, MA, USA). Amplification products were analyzed after electrophoresis on a 1% agarose gel stained with ethidium bromide. To identify detected Rickettsia spp., PCR products were purified and sequencing was performed as described (5). All sequences obtained were assembled and edited with Auto Assembler software version 1.4 (PerkinElmer). Sequences were analyzed by BLAST (www.ncbi.nlm.nih. gov/blast/Blast.cgi) sequencing analysis of sequences in the GenBank database.
Molecular Identification of Ticks
To help identify the ticks at the species level, molecular tools were used for some ticks that had not been morphologically identified at the species level and that were positive for rickettsiae. Amplification by PCR with T1B and T2A primers and sequencing of a 338-bp amplified fragment of the 12S rRNA gene of the ticks were performed as described (6).
A total of 370 specimens representing 7 species and 4 genera of ticks were collected. Tick species identified by taxonomic keys included Rh. sanguineus (106 specimens), Rh. bursa (76), Rh. turanicus (25), Haemaphysalis sulcata (79), Ha. punctata (6), Ixodes ricinus (14), and Dermacentor marginatus (11) (Figure). Some ticks, including engorged females or damaged specimens, were identified to genus only (18 Haemaphysalis sp. and 35 Hyalomma sp.). Most ticks (337) were collected from domestic animals; the rest were collected by flagging of vegetation (Table).
Rickettsial DNA was detected in 101 (27%) of 370 ticks by using a gltA PCR. Three (8.6%) of 35 Hyalomma spp. ticks contained rickettsia DNA with a gltA gene fragment that was 99.1% (765/772 bp) similar to that of R. aeschlimannii and 100% similar to the ompA gene of R. aeschlimannii. A 237-bp fragment of tick mitochondrial 12S rDNA gene was obtained from one of the R. aeschlimannii--infected ticks. The sequence of this fragment enabled definitive identification of the tick to the species level, with 100% similarity to H. marginatum marginatum (GenBank accession no. AF150034).
Five (4.7%) of 106 Rh. sanguineus ticks were positive for rickettsial DNA by PCR. For all samples, sequence analyses showed 99.8% (636/637) similarity with the gltA sequence and 100% similarity with the ompA sequence of R. massiliae. One R. massiliae--infected tick was evaluated by PCR amplification of the tick mitochondrial 12S rDNA gene; sequence analyses showed 99.6% (235/236) similarity to the corresponding 12S rDNA of Rh. sanguineus (GenBank accession no. AF133056).
A total of 5 (45.5%) of 11 D. marginatus ticks contained a rickettsia with a nucleotide sequence of gltA that was 99.2% (635/640 bp) similar to R. slovaca and 100% (533/533 bp) similar to the ompA sequence of R. slovaca. Rickettsial DNA was detected in 1 other specimen of D. marginatus. Amplified gltA and ompA fragments were se quenced and showed 99.3% (560/564 bp) similarity with the gltA gene of R. raoultii and 100% similarity with the ompA gene ofR. raoultii.
Five (35.7%) of 14 specimens of I. ricinus were positive by gltA PCR. Sequence analyses showed 100% homology with the corresponding gltA sequence of R. monacensis. OmpA sequences were obtained and showed 99.7% (585/587 bp) similarity with the corresponding sequence of R. monacensis. Four (28.6%) of 14 L ricinus ticks contained rickettsia with nucleotide sequences of gltA with 99.8% (633/634 bp) similarity to R. helvetica. The primer set Rr.190.70p-Rr.190.701n failed to amplify an ompA product in any specimens that were positive for the gltA gene of R. helvetica.
Sixty-one (77.2%) of 79 Ha. sulcata ticks, 3 (50%) of 6 Ha.punctata ticks, and 14 (77.7%) of 18 Haemaphysalis spp. ticks were positive by PCR for the primer set Rp CS.409p and Rp CS.1258n for the gltA gene. The gltA sequences obtained were different from all known Rickettsia spp. sequences deposited in GenBank. The most closely related sequence of gltA was designated "Ricketttsia endosymbiont of Haemaphysalis sulctata" (99.4% similarity; 484/487 bp). The next most closely related sequence of gltA, with 96% similarity, was R. felis. Results of the PCR with the ompA primer set Rr. 190.70p-Rr. 190.701 n were negative for all Haemaphysalis spp. ticks that were positive for the gltA gene.
None of the Rh. bursa and Rh. turanicus ticks harbored rickettsiae. All GenBank accession numbers used to compare sequences obtained from ticks are shown in the Table.
Before this study, only 2 SFG rickettsiae pathogenic to humans had been described in Morocco, R. conorii conorii, the agent of Mediterranean spotted fever, and the recently described R. aeschlimannii (2,3). In our study, in addition to R. aeschlimannii, we identified 3 other SFG pathogenic rickettsiae in Morocco: R. massiliae, R. slovaca, and R. monacensis. Furthermore, 2 tick-borne SFG Rickettsia spp. presumptively associated with human illnesses, R. helvetica and R. raoultii, and an undescribed bacterium have been identified.
DNA extraction and PCR were performed in different locations (Morocco and France), and all results were supported by 2 sets of primers. The gltA primers used in the first screening are known to amplify all known tick-borne rickettsiae (7). A second set of primers targeting the ompA gene was used to confirm positive results, although some rickettsia (e.g., R. helvetica) cannot be amplified by using this set. There were no cases in which multiple species of rickettsiae were detected in an infected tick, as in most of the similar molecular surveys published (1,2). Our results did not address prevalence and distribution of rickettsiae detected. Systematic sampling was not conducted. Also, some tick samples tested with rickettsial primers have not been tested with tick primers in parallel. Therefore, inhibitors that could be responsible for false-negative results and underestimation of infection rates cannot be ruled out.
R. aeschlimannii was isolated from H. marginatum marginatum ticks collected in Morocco in 1997 (3). This rickettsia has also been detected in H. marginatum rufipes ticks in Zimbabwe, Niger, and Mali; in H. marginatum marginatum in Portugal, Croatia, Spain, Greece, Algeria, and Egypt; and in both ticks in Corsica (2,8,9). H. marginatum marginatum is also known as the Mediterranean Hyalomma and may represent up to 42% of ticks found on cattle in Morocco. This tick is also a suspected reservoir of R. aeschlimannii because transstadial and transovarial transmission have been reported (8). As a result, the distribution of R. aeschlimannii may parallel that of H. marginatum marginatum.
In 2002, the pathogenic role of infection with R. aeschlimannii was demonstrated by PCR and serologic testing in a patient who returned to France from Morocco (4). Clinical signs in this 36-year-old man were fever, generalized maculopapular rashes, and a vesicular lesion of the ankle that became necrotic and resembled the typical tache noire of Mediterranean spotted fever. A second case was identified in a patient in South Africa in 2002 (10). This patient had an eschar around the attachment site. No additional symptoms developed, and treatment with antimicrobial drugs may have prevented progression of the syndrome.
A total of 4.7% of the Rh. sanguineus ticks tested were infected by R. massiliae. This rickettsia was isolated from Rh. sanguineus ticks collected near Marseille, France, in 1992 (11). It has been also found in Rh. sanguineus and Rh. turanicus in Greece, Spain, Portugal, Switzerland, central Africa, and Mali (2,12,13). Eremeeva et al. (14) recently reported detection and isolation of R. massiliae from 2 of 20 Rh. sanguineus ticks collected in eastern Arizona in the United States. R. massiliae may be commonly associated with these ticks, which are distributed worldwide. Transstadial and transovarial transmission of rickettsia in ticks has been reported (13).
In 2003, serologic findings from Spain showed that in 5 of 8 serum samples titers against R. massiliae were higher than those against R. conorii, the agent of Mediterranean spotted fever (12). The authors analyzed clinical symptoms of patients with strong serologic reactions against R. massiliae antigens but did not find relevant clinical differences between these patients and those with Mediterranean spotted fever. However, it is generally recognized that there are relatively few clinical differences among the different spotted fever diseases, and these differences are occasionally not taken into account by clinicians when reporting clinical data of patients (12). The only confirmed case of a person infected with R. massiliae was a patient hospitalized in Sicily, Italy. This patient had fever, a maculopapular rash on the palms of his hands and the soles of his feet, an eschar, and hepatomegaly. The strain of R. massiliae was isolated in Vero cells in 1985 and stored for 20 years in Sicily, but was not definitively identified until 2005 at the Unite de Rickettsies in Marseille, France (15).
The third SFG pathogenic rickettsia found in our study was R. slovaca in 5 (45.5%) of 11 D. marginatus. R. slovaca, which was identified in Dermacentor spp. ticks in Slovakia in 1968, has been subsequently found in D. marginatus and D. reticulatus in France, Switzerland, Portugal, Spain, Armenia, Poland, Bulgaria, Croatia, Russia, and Germany (2,16). These ticks may act as vectors and reservoirs of R. slovaca, which is maintained in ticks through transstadial and transovarial transmission (17). Human infection with R. slovaca was reported in France in 1997. Patients with similar clinical signs were observed in Spain, Bulgaria, and Hungary, where the syndrome was known as tick-borne lymphadenopathy or Dermacentor-borne necrosis erythema lymphadenopathy because of eschar at the tick bite site in the scalp and cervical lymphadenopathy (2,18-20). The incubation period ranges from 4 to 15 days. Low-grade fever and rash were present. The acute disease can be followed by fatigue and residual alopecia at the bite site (16,21). Recently, Gouriet et al. reported 14 new cases with tick-borne lymphadenopathy and Dermacentor-borne necrosis erythema lymphadenopathy in southern France during January 2004--May 2005 (22). In this group, tick-borne lymphadenopathy occurred mainly in young children and women and during the colder months (22). Overall, data in our study indicate that clinicians should be aware that this tick-related disorder may be found in Morocco.
R. raoultii is a recently described SFG rickettsia (23). In 1999, three new rickettsial genotypes, RpA4, DnS14, and DnS28, were identified in ticks collected in Russia by using PCR amplification and sequencing of 16S rDNA, gltA, and ompA genes. Genotypes identical to DnS14, DnS28, and RpA4 were thereafter detected in various areas in Russia and Kazakhstan in D. reticulatus, D. marginatus, and D. silvarum (24), in Germany and Poland in D. reticulatus (25,26), and in Spain, France, and Croatia in D. marginatus (23). Recently, cultivation of 2 rickettsial isolates genetically identical to Rickettsia sp. genotype DnS14, two rickettsial isolates genetically identical to Rickettsia sp. genotype RpA4, and 1 rickettsial isolate genetically identical to Rickettsia sp. genotype DnS28 was described (23). These isolates have been shown to fulfill the requirements for their classification within a new species, R. raoultii, by using multigene sequencing (16S rDNA, gltA, ompA, ompB, sca4, ftsY, and rpoB genes) and serotyping techniques (23,27). In our study, we detected R. raoultii in D. marginatus in Morocco. This tick is found in the cooler and more humid areas of the Mediterranean region associated with the Atlas Mountains. It is restricted to small areas of Morocco and Tunisia (28). Detection of R. raoultii in Morocco is of clinical relevance because it is suspected to be a human pathogen. In 2002, it was detected in D. marginatus obtained from a patient in France in whom typical clinical symptoms of tick-borne lymphadenopathy developed (23).
R. helvetica is another species identified in Morocco in this study. It is one of the few SFG species in which a commonly used ompA primer set does not amplify a PCR product (7,29). However, sequencing gltA enabled definitive identification. R. helvetica was isolated in Switzerland from I. ricinus in 1979 and has been identified in many European countries, where the tick is both a vector and a reservoir (2). The distribution of R. helvetica is not limited to Europe but extends into Asia (30). Our data show that the distribution of this bacterium extends into northern Africa. A small population of I. ricinus is present in Tunisia, Algeria, and Morocco. Our study was conducted in Taza, a humid area in the middle of the Atlas Mountains, which was the only site in Morocco that contained I. ricinus ticks (2).
R. helvetica was considered to be a nonpathogenic rickettsia for [approximately equal to] 20 years after its discovery. However, in 1999 it was implicated in fatal perimyocarditis in patients in Sweden (31). The authors of this study subsequently reported a controversial association between R. helvetica and sarcoidosis in Sweden (32) and found R. helvetica DNA in human aortic valves (33). However, the validity of these associations has been questioned by some rickettsiologists (2), and additional studies did not detect antibodies to rickettsia in a group of Scandinavian sarcoidosis patients (34). In 2000, seroconversion for R. helvetica was described in a patient in France with a nonspecific febrile illness (35). Serologic data, including cross-absorption and Western blotting, supported R. helvetica as the cause of disease. During 2003-2007, serologic findings in tickbite patients or in patients with fever of unknown origin from Switzerland, Italy, France, and Thailand were suggestive of acute or past R. helvetica infection (5,36). The few patients with a serology-based diagnosis had relatively mild, self-limited illnesses associated with headache and myalgias, and had a rash or eschar less frequently. Additional evaluation and isolation of the bacterium from clinical samples are needed to confirm the pathogenicity of R. helvetica.
We have detected in I. ricinus ticks a bacterium known as R. monacensis that was isolated from L ricinus collected in 1998 in a park in Munich, Germany (37). This rickettsia is also found in the literature by other names such as the Cadiz agent found in Spain and Rickettsia IRS3 and IRS4, detected in Slovakia and Bulgaria. More recently, it has been identified in I. ricinus in Hungary (38). Recently, 2 human cases of infection with R. monacensis were documented in Spain (39). Investigators isolated this agent from the blood of 2 patients with Mediterranean spotted fever-like illnesses. The first patient was an 84-year-old man from La Rioja, Spain. He had fever and maculopapular rash without any inoculation eschar. The second patient was a 59-year-old woman from the Basque region of Spain. She had a history of a tickbite, fever, and a rash at the tickbite site (39). With our results, R. monacensis joins the list of autochthonous Rickettsia spp. confirmed as human pathogens in Morocco.
A total of 69% of Haemaphysalis spp. ticks tested harbored an incompletely described rickettsia. A closely related gltA sequence was found in GenBank as Rickettsia endosymbiont of Haemaphysalis sulctata. Duh et al. detected this bacterium in Ha. sulcata ticks collected from sheep and goats in southern Croatia (40). Using molecular analysis of the complete gltA gene and a portion of ompB, these authors detected this bacterium in 795 (22.8%) ticks tested. Similar to our findings, these researchers could not amplify DNA by PCR for the ompA gene with the primers Rr. 190.70-Rr. 190.701. Identification and isolation of this bacterium are needed until the name provisionally proposed by Dub et al, "R. kastelanii" (40), is accepted (41).
These findings demonstrate that species of ticks and several pathogens causing tick-transmitted diseases may be prevalent in the same area. Our study also detected R. slovaca, R. helvetica, R. monacensis, R. raoultii, and an incompletely described rickettsia in Morocco. Clinicians in Morocco and those who may see patients returning from this country should be aware that many species of rickettsiae are present in this region and should consider a range of spotted fever rickettsial diseases in differential diagnosis of patients with febrile illnesses. Our data increase information on distribution of SFG rickettsiae in Morocco. Additional studies are needed to determine the epidemiologic and clinical relevance of different rickettsioses in this region.
DOI: 10.3201/eid 1407.070096
We thank Christopher D. Paddock for editing the manuscript.
Dr Sarih is chief of the Laboratory of Medical Entomology at the Pasteur Institute in Casablanca, Morocco. His research interests include emerging tick-borne diseases.
(1.) Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis. 2001;32:897-928. DOI: 10.1086/319347
(2.) Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the word: emerging diseases challenging old concepts. Clin Microbiol Rev. 2005;18:719-56. DOI: 10.1128/CMR.18.4.719-756.2005
(3.) Beati L, Meskini M, Thiers B, Raoult D. Rickettsia aeschlimannii sp. nov., a new spotted fever group rickettsia associated with Hyalomma marginatum ticks. Int J Syst Bacteriol. 1997;47:548-54.
(4.) Raoult D, Fournier PE, Abboud P, Caron F. First documented human Rickettsia aeschlimannii infection. Emerg Infect Dis. 2002;8:748-9.
(5.) Parola P, Miller RS, McDaniel P, Telford SR III, Rolain JM, Wongsrichanalai C, et al. Emerging rickettsioses of the Thai-Myanmar border. Emerg infect Dis. 2003;9:592-5.
(6.) Beati L, Keirans JE. Analysis of the systematic relationships among ticks of the genera Rhipicephalus and Boophilus (Acari: Ixodidae) based on mitochondrial 12S ribosomal DNA gene sequences and morphological characters. J Parasitol. 2001;87:32-48.
(7.) Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoersdorff A, Blanco JR, et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect. 2004;10:1108-32. DOI: 10.111/j.1469-0691.2004.01019.x
(8.) Matsumoto K, Parola P, Brouqui P, Raoult D. Rickettsia aeschlimannii in Hyalomma ticks from Corsica. Eur J Clin Microbiol Infect Dis. 2004;23:732-4. DOE 10.1007/s10096-004-1190-9
(9.) Loftis AD, Reeves WK, Szumlas DE, Abbassy MM, Helmy IM, Moriarity JR, et al. Rickettsial agents in Egyptian ticks collected from domestic animals. Exp Appl Acarol. 2006;40:67-81. DOI: 10.1007/ s10493-006-9025-2
(10.) Pretorius AM, Birtles RJ. Rickettsia aeschlimannii: a new pathogenetic spotted fever group rickettsia, South Africa. Emerg Infect Dis. 2002;8:874.
(11.) Beati L, Raoult D. Rickettsia massiliae sp.nov., a new spotted fever group rickettsia. Int J Syst Bacteriol. 1993;43:839-40.
(12.) Cardenosa N, Segura F, Raoult D. Serosurvey among Mediterranean spotted fever patients of a new spotted fever group rickettsial strain (Bar29). Eur J Epidemiol. 2003;18:351-6. DOI: 10.1023/ A:1023654400796
(13.) Matsumoto K, Ogawa M, Brouqui P, Raoult D, Parola P. Transmission of Rickettsia massiliae in the tick, Rhipicephalus turanicus. Med Vet Entomol. 2005;19:263-70. DOI: 10.1111/j.1365-2915.2005.00569.x
(14.) Eremeeva ME, Bosserman EA, Demma LJ, Zambrano ML, Blau DM, Dasch GA. Isolation and identification of Rickettsia massiliae from Rhipicephalus sanguineus ticks collected in Arizona. Appl Environ Microbiol. 2006;72:5569-77. DOI: 10.1128/AEM.00122-06
(15.) Vitale G, Mansueto S, Rolain JM, Raoult D. Rickettsia massiliae human isolation. Emerg Infect Dis. 2006;12:174-5.
(16.) Raoult D, Lakos A, Fenollar F, Beytout J, Brouqui P, Fournier PE. Spotless rickettsiosis caused by Rickettsia slovaca and associated with Dermacentor ticks. Clin Infect Dis. 2002;34:1331-6. DOI: 10.1086/340100
(17.) Rehacek J. Rickettsia slovaca, the organism and its ecology. Acta Scientiarum Naturalium Academiae Scientiarum Bohemoslovacae Brno. 1984;18:1-50.
(18.) Lakos A. Tick-borne lymphadenopathy--a new rickettsial disease? Lancet. 1997;350:1006. DOI: 10.1016/S0140-6736(05)64072-X
(19.) Raoult D, Berbis P, Roux V, Xu W, Maurin M. A new tick-transmitted disease due to Rickettsia slovaca. Lancet. 1997;350:112-3. DOI: 10.1016/S0140-6736(05)61814-4
(20.) Cazorla C, Enea M, Lucht F, Raoult D. First isolation of Rickettsia slovaea from a patient, France. Emerg Infect Dis. 2003;9:135.
(21.) Oteo JA, Ibarra V, Blanco JR, Martinez de Artola V, Marquez FJ, Portillo A, et al. Dermacentor-borne necrosis erythema and lymphadenopathy: clinical and epidemiological features of a new tick-borne disease. Clin Microbiol Infect. 2004;10:327-31. DOI: 10.1111/j.1198-743X.2004.00782.x
(22.) Gouriet F, Rolain JM, Raoult D. Rickettsia slovaca infection, France. Emerg Infect Dis. 2006;12:521-3.
(23.) Mediannikov OY, Matsumoto K, Samoylenko I, Drancourt M, Roux V, Rydkina E, et al. Rickettsia raoultii sp. nov., a new spotted fever group rickettsia associated with Dermacentor ticks in Europe and Russia. Int J Syst Evol Microbiol. 2008. In press.
(24.) Shpynov S, Fournier PE, Rudakov N, Tankibaev M, Tarasevich I, Raoult D. Detection of a rickettsia closely related to Rickettsia aeschlimannii, "Rickettsia heilongjiangensis", Rickettsia sp. strain RpA4, and Ehrlichia muris in ticks collected in Russia and Kazakhstan. J Clin Microbiol. 2004;42:2221-3. DOI: 10.1128/ JCM.42.5.2221-2223.2004
(25.) Stanczak J. Detection of spotted fever group (SFG) rickettsiae in Dermacentor reticulatus (Acari: Ixodidae) in Poland. Int J Med Microbiol. 2006;296(Suppl 40):144-8. DOI: 10.1016/j.ijmm.2006.01.014
(26.) Dautel H, Dippel C, Oehme R, Hartelt K, Schettler E. Evidence for an increased geographical distribution of Dermacentor reticulatus in Germany and detection of Rickettsia sp. RpA4. Int J Med Microbiol. 2006;296(Supp140):149-56. DOI: 10.1016/j.ijmm.2006.01.013
(27.) Mediannikov OY, Parola P, Raoult D. Other tick-borne rickettsioses. In: Parola P, Raoult D, editors. Rickettsial diseases: infectious diseases and therapy. New York: Informa Healthcare; 2007. p. 139-62.
(28.) Estrada-Pena A, Bouattour A, Camicas J-L, Walker AR. Ticks of domestic animals in the Mediterranean region. Zaragosa (Spain): University of Zaragoza; 2004.
(29.) Parola P, Beati L, Cambon M, Raoult D. First isolation of Rickettsia helvetica from Ixodes ricinus ticks in France. Eur J Clin Microbiol Infect Dis. 1998;17:95-100.
(30.) Fournier PE, Fujita H, Takada N, Raoult D. Genetic identification of rickettsiae isolated from ticks in Japan. J Clin Microbiol. 2002;40:2176-81. DOI: 10.1128/JCM.40.6.2176-2181.2002
(31.) Nilsson K, Lindquist O, Pahlson C. Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet. 1999;354:1169-73. DOI: 10.1016/S0140-6736(99)04093-3
(32.) Nilsson K, Pahlson C, Lukinius A, Eriksson L, Nilsson L, Lindquist O. Presence of Rickettsia helvetica in granulomatous tissue from patients with sarcoidosis. J Infect Dis. 2002;185:1128 38. DOI: 10.1086/339962
(33.) Nilsson K, Liu A, Pahlson C, Lindquist O. Demonstration of intracellular microorganisms (Rickettsia spp., Chlamydia pneumoniae, Bartonella spp. in pathological human aortic valves by PCR. J Infect. 2005;50:46-52. DOI: 10.1016/j.jinf.2003.10.009
(34.) Planck A, Eklund A, Grunewald J, Vene S. No serological evidence of Rickettsia helvetica infection in Scandinavian sarcoidosis patients. Eur Respir J. 2004;24:811-3. DOI: 10.1183/09031936.04.00014604
(35.) Fournier PE, Gunnenberger F, Jaulhac B, Gastinger G, Raoult D. Evidence of Rickettsia helvetica infection in humans, eastern France. Emerg Infect Dis. 2000;6:389-92.
(36.) Fournier PE, Allombert C, Supputamongkol Y, Caruso G, Brouqui P, Raoult D. Anernptive fever associated with antibodies to Rickettsia helvetica in Europe and Thailand. J Clin Microbiol. 2004;42:816-8. DOI: 10.1128/JCM.42.2.816-818.2004
(37.) Simser JA, Palmer AT, Fingerle V, Wilske B, Kurtti TJ, Munderloh UG. Rickettsia monacensis sp. nov., a spotted fever group Rickettsia, from ticks (Ixodes ricinus) collected in a European city park. Appl Environ Microbiol. 2002;68:4559 66. DOI: 10.1128/ AEM.68.9.4559-4566.2002
(38.) Sreter-Lancz Z, Szell Z, Kovacs G, Egyed L, Marialigeti K, Sreter T. Rickettsiae of the spotted-fever group in ixodid ticks from Hungary: identification of a new genotype ('Candidatus Rickettsia kotlanii'). Ann Trop Med Parasitol. 2006;100:229-36. DOI: 10.1179/136485906X91468
(39.) Jado I, Oteo JA, Aldamiz M, Gil H, Escudero R, Ibarra V, et al. Rickettsia monacensis and human disease, Spain. Emerg Infect Dis. 2007;13:1405-7.
(40.) Duh D, Punda-Polic V, Trilar T, Petrovec M, Bradaric N, AvsicZupanc T. Molecular identification of Rickettsia felis-like bacteria in Haemaphysalis sulcata ticks collected from domestic animals in southern Croatia. Ann N Y Acad Sci. 2006;1078:347-51. DOI: 10.1196/annals.1374.068
(41.) Raoult D, Fournier PE, Eremeeva M, Graves S, Kelly PJ, Oteo JA, et al. Naming of rickettsiae and rickettsial diseases. Ann N Y Acad Sci.2005;1063:1-12. DOI: 10.1196/annals.1355.002
Address for correspondence: Philippe Parola, Unite des Rickettsies, Centre National de la Recherche Scientifique--Institut de Recherche pour le Developpement, Unite Mixte de Recherche 6236, World Health Organization Collaborative Center for Rickettsioses and Other Arthropod Borne Bacterial Diseases, Faculte de Medecine, 27 Bd Jean Moulin, 13005 Marseille, France; email: firstname.lastname@example.org
Mhammed Sarih, * (1) Cristina Socolovschi, ([dagger]) (1) Najma Boudebouch, * Mohammed Hassar, * Didier Raoult, ([dagger]) and Philippe Parola ([dagger])
* Institut Pasteur du Maroc, Casablanca, Morocco; and ([dagger]) World Health Organization Collaborative Center for Rickettsioses and Other Arthropod Borne Bacterial Diseases, Marseille, France (1) These authors contributed equally to this article.
Table. Detection and identification of spotted fever group Rickettsia spp. from ticks collected in Morocco, by PCR and DNA sequencing Rickettsial gene targeted/no. ticks positive Tick species (no. specimens by PCR/no. tested) Host examined * Dermacentor marginatus (11) Vegetation gltA/6/11 ompA/6/6 Hyalomma marginatum Domestic animals gltA/3/35 marginatum (35) ompA/3/3 Haemaphysalis sulctata (79) Domestic animals gltA/61/79 ompA/0/61 Ha. punctata (6) Domestic animals gltA/3/6 ompA/0/3 Haemaphysalis sp. (18) Vegetation gltA/14/18 ompA/0/14 Ixodes ricinus (14) Vegetation gltA/9/14 ompA/5/9 Rhipicephalus sanguineus (106) Domestic animals gltA/5/106 ompA/5/5 Rh. bursa (76) Domestic animals gltA/0/76 Rh. turanicus (25) Domestic animals gltA/0/25 Rickettsial gene targeted/no. ticks positive Identification by by PCR/no. gene sequence GenBank accession examined * (no. identified/no. tested) no. gltA/6/11 R. slovaca (5/6), U59725, D0365803 R. raoultii (1/6) ompA/6/6 R. slovaca (5/6), U43808, DQ365799 R. raoultii (1 /6) gltA/3/35 R. aeschlimannii U59722 ompA/3/3 R. aeschlimannii DQ379982 gltA/61/79 "Rickettsia endosymbiont of DQ081187 Ha. Sulctata" ("R. kastelanii") ompA/0/61 -- -- gltA/3/6 "Rickettsia endosymbiont of DQ081187 Ha. Sulctata" ("R. kastelanii") ompA/0/3 gltA/14/18 "Rickettsia endosymbiont of DQ081187 Ha. Sulctata" ("R. kastelanii") ompA/0/14 -- -- gltA/9/14 R. monacensis (5/9), AF140706, U59723 R. helvetica (4/9) ompA/5/9 R. monacensis (5/9) AJ427885 gltA/5/106 R. massiliae U59720 ompA/5/5 R. massiliae U43792 gltA/0/76 -- -- gltA/0/25 -- -- * gltA, citrate synthase A; ompA, outer membrane protein A. Only ticks positive for the gltA gene were tested for the ompA gene.
|Printer friendly Cite/link Email Feedback|
|Author:||Sarih, Mhammed; Socolovschi, Cristina; Boudebouch, Najma; Hassar, Mohammed; Raoult, Didier; Parola,|
|Publication:||Emerging Infectious Diseases|
|Date:||Jul 1, 2008|
|Previous Article:||Determinants of cluster size in large, population-based molecular epidemiology study of tuberculosis, Northern Malawi.|
|Next Article:||Transmission of Bartonella henselae by Ixodes ricinus.|